ATE133169T1 - Indol derivate als ''5-ht1-like'' agonisten - Google Patents
Indol derivate als ''5-ht1-like'' agonistenInfo
- Publication number
- ATE133169T1 ATE133169T1 AT93906620T AT93906620T ATE133169T1 AT E133169 T1 ATE133169 T1 AT E133169T1 AT 93906620 T AT93906620 T AT 93906620T AT 93906620 T AT93906620 T AT 93906620T AT E133169 T1 ATE133169 T1 AT E133169T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- date oct
- sec
- optionally substituted
- agonists
- Prior art date
Links
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical class C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title 1
- 239000000556 agonist Substances 0.000 title 1
- 229940054051 antipsychotic indole derivative Drugs 0.000 title 1
- 125000002947 alkylene group Chemical group 0.000 abstract 2
- 206010009094 Chronic paroxysmal hemicrania Diseases 0.000 abstract 1
- 208000006561 Cluster Headache Diseases 0.000 abstract 1
- 206010019233 Headaches Diseases 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 208000018912 cluster headache syndrome Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000392 cycloalkenyl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 231100000869 headache Toxicity 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 208000007777 paroxysmal Hemicrania Diseases 0.000 abstract 1
- 239000000018 receptor agonist Substances 0.000 abstract 1
- 229940044601 receptor agonist Drugs 0.000 abstract 1
- 102220315634 rs1196125127 Human genes 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000019553 vascular disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929207930A GB9207930D0 (en) | 1992-04-10 | 1992-04-10 | Indoles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE133169T1 true ATE133169T1 (de) | 1996-02-15 |
Family
ID=10713831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93906620T ATE133169T1 (de) | 1992-04-10 | 1993-03-25 | Indol derivate als ''5-ht1-like'' agonisten |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5639779A (de) |
| EP (1) | EP0635014B1 (de) |
| JP (1) | JP2784265B2 (de) |
| CN (1) | CN1082039A (de) |
| AT (1) | ATE133169T1 (de) |
| AU (1) | AU3752593A (de) |
| CA (1) | CA2131000C (de) |
| DE (1) | DE69301357T2 (de) |
| DK (1) | DK0635014T3 (de) |
| ES (1) | ES2082639T3 (de) |
| FI (1) | FI111255B (de) |
| GB (1) | GB9207930D0 (de) |
| GR (1) | GR3019132T3 (de) |
| IL (1) | IL105311A0 (de) |
| WO (1) | WO1993021177A1 (de) |
| ZA (1) | ZA932534B (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5559129A (en) * | 1990-10-15 | 1996-09-24 | Pfizer Inc | Indole derivatives |
| US5607951A (en) * | 1990-10-15 | 1997-03-04 | Pfizer Inc | Indole derivatives |
| US5545644A (en) * | 1990-10-15 | 1996-08-13 | Pfizer Inc. | Indole derivatives |
| US5578612A (en) * | 1990-10-15 | 1996-11-26 | Pfizer Inc. | Indole derivatives |
| US5559246A (en) * | 1990-10-15 | 1996-09-24 | Pfizer Inc. | Indole derivatives |
| KR100191973B1 (ko) * | 1993-08-31 | 1999-06-15 | 디. 제이. 우드, 스피겔 알렌 제이 | 5-아릴인돌 유도체 |
| GB9417310D0 (en) | 1994-08-27 | 1994-10-19 | Pfizer Ltd | Therapeutic agents |
| GB9420503D0 (en) * | 1994-10-11 | 1994-11-23 | Pfizer Ltd | Therapeutic agents |
| GB9420529D0 (en) | 1994-10-12 | 1994-11-30 | Pfizer Ltd | Indoles |
| US5994352A (en) * | 1998-11-13 | 1999-11-30 | Pfizer Inc. | 5-arylindole derivatives |
| GB9923314D0 (en) * | 1999-10-01 | 1999-12-08 | Pfizer Ltd | Acylation process |
| EP1132389A1 (de) * | 2000-03-06 | 2001-09-12 | Vernalis Research Limited | Neue Azaindolyl-Derivate für die Behandlung von Fettleibigheit |
| WO2011089614A1 (en) | 2010-01-19 | 2011-07-28 | Sms Pharmaceuticals Limited | PROCESS FOR PREPARING ELETRIPTAN HYDROBROMIDE HAVING α-FORM |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA795239B (en) * | 1978-10-12 | 1980-11-26 | Glaxo Group Ltd | Heterocyclic compounds |
| FR2488606A1 (fr) * | 1980-08-12 | 1982-02-19 | Glaxo Group Ltd | Derives indoliques, leur preparation et leurs applications en tant que medicaments |
| BE889931A (fr) * | 1980-08-12 | 1982-02-11 | Glaxo Group Ltd | Derives indoliques, leur preparation et leurs applications en tant que medicaments |
| GB8600397D0 (en) * | 1986-01-08 | 1986-02-12 | Glaxo Group Ltd | Chemical compounds |
| GB8719167D0 (en) * | 1987-08-13 | 1987-09-23 | Glaxo Group Ltd | Chemical compounds |
| GB8724912D0 (en) * | 1987-10-23 | 1987-11-25 | Wellcome Found | Indole derivatives |
| GB8819024D0 (en) * | 1988-08-10 | 1988-09-14 | Glaxo Group Ltd | Chemical compounds |
| IL96891A0 (en) * | 1990-01-17 | 1992-03-29 | Merck Sharp & Dohme | Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them |
| PL166214B1 (pl) * | 1990-06-07 | 1995-04-28 | Wellcome Found | Sposób wytwarzania nowych pochodnych indolu PL PL PL PL PL PL PL |
| DE9190141U1 (de) * | 1990-10-15 | 1993-07-15 | Pfizer Inc., New York, N.Y. | Indolderivate |
| US5208248A (en) * | 1991-01-11 | 1993-05-04 | Merck Sharpe & Dohme, Ltd. | Indazole-substituted five-membered heteroaromatic compounds |
| CZ283018B6 (cs) * | 1991-02-01 | 1997-12-17 | Merck Sharp And Dohme Limited | Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi |
| US5409941A (en) * | 1992-02-03 | 1995-04-25 | Pfizer Inc. | 5-heteroyl indole derivatives |
-
1992
- 1992-04-10 GB GB929207930A patent/GB9207930D0/en active Pending
-
1993
- 1993-03-25 EP EP93906620A patent/EP0635014B1/de not_active Expired - Lifetime
- 1993-03-25 DK DK93906620.5T patent/DK0635014T3/da active
- 1993-03-25 CA CA002131000A patent/CA2131000C/en not_active Expired - Fee Related
- 1993-03-25 US US08/313,106 patent/US5639779A/en not_active Expired - Fee Related
- 1993-03-25 AT AT93906620T patent/ATE133169T1/de not_active IP Right Cessation
- 1993-03-25 AU AU37525/93A patent/AU3752593A/en not_active Abandoned
- 1993-03-25 DE DE69301357T patent/DE69301357T2/de not_active Expired - Fee Related
- 1993-03-25 JP JP5517929A patent/JP2784265B2/ja not_active Expired - Fee Related
- 1993-03-25 ES ES93906620T patent/ES2082639T3/es not_active Expired - Lifetime
- 1993-03-25 WO PCT/EP1993/000738 patent/WO1993021177A1/en active IP Right Grant
- 1993-04-05 IL IL105311A patent/IL105311A0/xx unknown
- 1993-04-08 ZA ZA932534A patent/ZA932534B/xx unknown
- 1993-04-10 CN CN93105712A patent/CN1082039A/zh active Pending
-
1994
- 1994-10-07 FI FI944727A patent/FI111255B/fi not_active IP Right Cessation
-
1996
- 1996-02-28 GR GR960400556T patent/GR3019132T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US5639779A (en) | 1997-06-17 |
| GR3019132T3 (en) | 1996-05-31 |
| EP0635014B1 (de) | 1996-01-17 |
| ES2082639T3 (es) | 1996-03-16 |
| WO1993021177A1 (en) | 1993-10-28 |
| JP2784265B2 (ja) | 1998-08-06 |
| EP0635014A1 (de) | 1995-01-25 |
| GB9207930D0 (en) | 1992-05-27 |
| FI111255B (fi) | 2003-06-30 |
| DE69301357D1 (de) | 1996-02-29 |
| FI944727A (fi) | 1994-10-07 |
| JPH07505402A (ja) | 1995-06-15 |
| CA2131000C (en) | 1998-09-22 |
| CA2131000A1 (en) | 1993-10-28 |
| FI944727A0 (fi) | 1994-10-07 |
| DE69301357T2 (de) | 1996-06-13 |
| AU3752593A (en) | 1993-11-18 |
| CN1082039A (zh) | 1994-02-16 |
| ZA932534B (en) | 1994-10-08 |
| DK0635014T3 (da) | 1996-02-12 |
| IL105311A0 (en) | 1993-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE133169T1 (de) | Indol derivate als ''5-ht1-like'' agonisten | |
| ATE171445T1 (de) | Perhydroisoindolderivate als substanz p antagonisten | |
| FI954944A0 (fi) | Indolijohdannaisia 5-HT1-kaltaisina agonisteina käytettäväksi migreenin hoitoon | |
| BR9206810A (pt) | Derivados de indol | |
| DE3882614D1 (de) | Indol-derivate. | |
| DK391289D0 (da) | Indolderivater | |
| ATE218566T1 (de) | Indol derivate als 5-ht1 agoniste | |
| FI943931A0 (fi) | Indolijohdannaisia steroidi-5alfa-reduktaasin inhibiittoreina | |
| DE69501791D1 (de) | Indol-derivate als 5-ht1-like agonisten | |
| YU29496A (sh) | So pirolidinil metil indola |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EEIH | Change in the person of patent owner | ||
| REN | Ceased due to non-payment of the annual fee |